NEW YORK (GenomeWeb) – Envisagenics announced today that it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health to further develop its cloud-based platform that detects, quantifies, and interprets alternative splicing (AS) errors from RNA sequencing data for drug discovery.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.